FX.co ★ Sanara MedTech Names Jake Waldrop COO, Effective April 15; Stock Up In Pre-market

Sanara MedTech Inc., a frontrunner in the medical technology industry, confirmed recent executive team changes on Friday. Jake Waldrop is set to take on the role of Chief Operating Officer, as of April 15, while Tyler Palmer assumed responsibilities as the Chief Corporate Development and Strategy Officer on April 1.

Waldrop, who has an impressive twenty-year track record, recently served as the Chief Financial Officer at Trilliant Surgical. After the business changed hands to Enovis (formerly DJO) in the early days of 2021, Waldrop transitioned into the role of Vice President of Finance and Integrations, managing financial affairs for the newly established Foot and Ankle division of Enovis. Waldrop's professional journey started in public accounting at KPMG.

In contrast, Palmer held the position of Senior Vice President of Corporate Development, Strategy, and Product at AQuity Solutions before joining Sanara. AQuity Solutions specializes in outsourced revenue cycle and clinical documentation solution services.

Commenting on the significant appointments, Sanara's Chief Executive Officer, Zach Fleming praised Waldrop and Palmer for their plentiful experience in the fields of medical device and wound care. He further expressed his enthusiasm for their addition to the team, hopeful that their expertise would contribute to the mission of improving clinical outcomes and decreasing healthcare costs.

Just ahead of market activity on the Nasdaq on Friday, shares showed promising prospects at $35.37, marking a 3.45% increase.